Propanc Biopharma Plans to Purchase $100 Million Worth of Ethereum in the Next 12 Months
By: theblockbeats.news|2025/09/02 13:52:27
BlockBeats News, September 2nd, US-listed biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months. Propanc Biopharma stated that this move will enhance its overall corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisition.
U.S. publicly traded company Empery Digital has announced an additional purchase of 16.51 BTC, increasing its total holdings to 4,081.39 BTC.
Data: Avalon Labs has collected a total of $5.48 million in fees since June.
You may also like
Share
Gainers
Latest Crypto News
10:15
BiyaPay Analyst: HashKey's Listing Imminent, Hong Kong Stock Market Welcomes First Cryptocurrency Compliance Giant
09:45
A certain whale has accumulated 2.33 million LINK over the past six months, currently facing an unrealized loss of $10.5 million
09:45
CoinShares: Digital Asset Investment Products Saw $1.07 Billion in Net Inflows Last Week
09:45
Abraxas Capital has allocated half of its funds to purchase HYPE spot, with a position reaching $56 million.
09:15
BNP Paribas: Fed to Continue Cutting Interest Rates Next Year, Room for Further Decline in US Bond Yields
Read more
Community
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com